Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men.

Andrology

Volumn 1, Issue 1, 2013, Pages 24-28

  Maggio, M ^a   Snyder, P J ^b   Ceda, G P ^b   Milaneschi, Y ^b   Luci, M ^b   Cattabiani, C ^b   Masoni, S ^b   Vignali, A ^b   Volpi, R ^b   Lauretani, F ^b   Peachey, H ^b   Valenti, G ^b   Cappola, A R ^b   Longo, D ^b   Ferrucci, L ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPO PROTEIN, HUMAN; ERYTHROPOIETIN; HEMOGLOBIN; TESTOSTERONE;

AGED; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEMATOPOIESIS; HORMONE SUBSTITUTION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TRANSDERMAL PATCH; TREATMENT OUTCOME; UNITED STATES; UPREGULATION;

ADMINISTRATION, CUTANEOUS; AGED; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; HEMATOPOIESIS; HEMOGLOBINS; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; PHILADELPHIA; TESTOSTERONE; TIME FACTORS; TRANSDERMAL PATCH; TREATMENT OUTCOME; UP-REGULATION;

EID: 84878730065     PISSN: None     EISSN: 20472927     Source Type: Journal    
DOI: None     Document Type: Article

References (0)